Ethics and Clinical Research: Improving Transparency and Informed Consent in Phase I Oncology Trials.
作者信息
Frankel Paul H, Groshen Susan, Beumer Jan H, Cleveland Laura, Kim Edward S, Karp Judith E
机构信息
Department of Computational and Quantitative Medicine, City of Hope, Duarte, CA.
Department of Preventive Medicine, University of Southern California, Los Angeles, CA.
出版信息
J Clin Oncol. 2023 Apr 20;41(12):2155-2158. doi: 10.1200/JCO.22.01736. Epub 2023 Feb 1.
Abstract
摘要
相似文献
1
Ethics and Clinical Research: Improving Transparency and Informed Consent in Phase I Oncology Trials.伦理与临床研究：提高肿瘤学I期试验的透明度和知情同意率
J Clin Oncol. 2023 Apr 20;41(12):2155-2158. doi: 10.1200/JCO.22.01736. Epub 2023 Feb 1.
2
Communication about the risks and benefits of phase I pediatric oncology trials.关于儿科肿瘤I期试验风险与益处的沟通。
Contemp Clin Trials. 2015 Mar;41:139-45. doi: 10.1016/j.cct.2015.01.015. Epub 2015 Jan 29.
3
Voluntary Informed Consent in Paediatric Oncology Research.儿科肿瘤学研究中的自愿知情同意
Bioethics. 2016 Jul;30(6):440-50. doi: 10.1111/bioe.12237. Epub 2015 Dec 21.
4
Comparison of the informed consent process for randomized clinical trials in pediatric and adult oncology.儿科与成人肿瘤学随机临床试验的知情同意过程比较
J Clin Oncol. 2004 Jul 1;22(13):2708-17. doi: 10.1200/JCO.2004.10.034.
5
A Qualitative Study into Dependent Relationships and Voluntary Informed Consent for Research in Pediatric Oncology.一项关于儿童肿瘤学研究中依赖关系与自愿知情同意的定性研究。
Paediatr Drugs. 2016 Apr;18(2):145-56. doi: 10.1007/s40272-015-0158-9.
6
Suggestions from adolescents, young adults, and parents for improving informed consent in phase 1 pediatric oncology trials.青少年、青年和家长对改善 1 期儿科肿瘤试验中知情同意的建议。
Cancer. 2013 Dec 1;119(23):4154-61. doi: 10.1002/cncr.28335. Epub 2013 Sep 4.
7
Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective.治疗性研究对知情同意及临床试验伦理的影响：肿瘤医学视角
J Clin Oncol. 1999 May;17(5):1601-17. doi: 10.1200/JCO.1999.17.5.1601.
8
[Clinical research and informed consent. Ethical and deontologic aspects].[临床研究与知情同意。伦理与道义层面]
Bull Cancer. 1997 Mar;84(3):311-2.
9
Ethical Considerations for Phase I Trials in Oncology.肿瘤学 I 期临床试验的伦理考虑
J Clin Oncol. 2022 Oct 20;40(30):3474-3488. doi: 10.1200/JCO.21.02125. Epub 2022 Mar 11.
10
Phase I pediatric oncology trials.I期儿科肿瘤试验。
J Pediatr Oncol Nurs. 1995 Jul;12(3):143-5. doi: 10.1177/104345429501200311.
引用本文的文献
1
Quality of Informed Consent via Telemedicine Compared With In-Person for Clinical Cancer Research.与面对面方式相比，通过远程医疗获取临床癌症研究知情同意书的质量
JCO Oncol Pract. 2025 Jun 16:OP2401041. doi: 10.1200/OP-24-01041.
2
CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials.CONSORT-DEFINE解释与阐述：提高早期剂量探索性临床试验报告质量和影响力的建议
EClinicalMedicine. 2025 Jan 10;79:102987. doi: 10.1016/j.eclinm.2024.102987. eCollection 2025 Jan.
3
The next frontier in immunotherapy: potential and challenges of CAR-macrophages.免疫疗法的下一个前沿领域：嵌合抗原受体巨噬细胞的潜力与挑战。
Exp Hematol Oncol. 2024 Aug 5;13(1):76. doi: 10.1186/s40164-024-00549-9.
4
Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance.提高早期剂量发现临床试验的报告质量和影响力：CONSORT 剂量发现扩展（CONSORT-DEFINE）指南。
BMJ. 2023 Oct 20;383:e076387. doi: 10.1136/bmj-2023-076387.
5
Assessing the reporting quality of early phase dose-finding trial protocols: a methodological review.评估早期剂量探索试验方案的报告质量：一项方法学综述。
EClinicalMedicine. 2023 May 25;60:102020. doi: 10.1016/j.eclinm.2023.102020. eCollection 2023 Jun.
本文引用的文献
1
The Drug-Dosing Conundrum in Oncology - When Less Is More.肿瘤学中的给药难题——少即是多。
N Engl J Med. 2021 Oct 14;385(16):1445-1447. doi: 10.1056/NEJMp2109826. Epub 2021 Oct 9.
2
Untenable dosing: A common pitfall of modern DLT-targeting Phase I designs in oncology.不可持续的剂量：肿瘤学中现代 DLT 靶向 I 期设计的常见陷阱。
Curr Probl Cancer. 2020 Dec;44(6):100583. doi: 10.1016/j.currproblcancer.2020.100583. Epub 2020 May 7.
3
Model of a Queuing Approach for Patient Accrual in Phase 1 Oncology Studies.用于 1 期肿瘤学研究患者入组的排队方法模型。
JAMA Netw Open. 2020 May 1;3(5):e204787. doi: 10.1001/jamanetworkopen.2020.4787.
4
Phase I trials as valid therapeutic options for patients with cancer.I 期临床试验是癌症患者有效的治疗选择。
Nat Rev Clin Oncol. 2019 Dec;16(12):773-778. doi: 10.1038/s41571-019-0262-9. Epub 2019 Sep 2.
5
Compliance with requirement to report results on the EU Clinical Trials Register: cohort study and web resource.遵守在欧盟临床试验注册库中报告结果的要求：队列研究与网络资源
BMJ. 2018 Sep 12;362:k3218. doi: 10.1136/bmj.k3218.
6
Do Patients With Advanced Cancer Have the Ability to Make Informed Decisions for Participation in Phase I Clinical Trials?晚期癌症患者是否有能力参与 I 期临床试验做出知情决策？
J Clin Oncol. 2018 Aug 20;36(24):2483-2491. doi: 10.1200/JCO.2017.73.3592. Epub 2018 Jul 9.
7
Adaptive dose-finding studies: a review of model-guided phase I clinical trials.适应性剂量探索研究：模型引导的I期临床试验综述
J Clin Oncol. 2014 Aug 10;32(23):2505-11. doi: 10.1200/JCO.2013.54.6051. Epub 2014 Jun 30.
8
A modified toxicity probability interval method for dose-finding trials.改良毒性概率区间法在探索性剂量试验中的应用。
Clin Trials. 2010 Dec;7(6):653-63. doi: 10.1177/1740774510382799. Epub 2010 Oct 8.
9
Benefit in phase 1 oncology trials: therapeutic misconception or reasonable treatment option?肿瘤学1期试验中的益处：治疗误解还是合理的治疗选择？
Clin Trials. 2008;5(6):617-23. doi: 10.1177/1740774508097576.
10
Critical aspects of the Bayesian approach to phase I cancer trials.贝叶斯方法在I期癌症试验中的关键方面。
Stat Med. 2008 Jun 15;27(13):2420-39. doi: 10.1002/sim.3230.
Zotero 插件